- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
There is constant pressure for clinicians to practise evidence-based medicine. Cochrane Reviews are an important source of the evidence which informs clinical decisions but can still require considerable time to read and digest. This Cochrane Handbook of Alcohol and Drug Misuse serves as a concise guide to the evidence base for relevant interventions, highlighting the key points of Cochrane reviews for the busy practitioner.
Each review is analysed in a structured format, starting with the question, a brief background and a summary answer, followed by the results presented in comprehensive…mehr
Andere Kunden interessierten sich auch für
- Tracey J JarvisTreatment Approaches for Alcohol and Drug Dependence98,99 €
- Clinical Handbook of Adolescent Addiction105,99 €
- Hermine L. Graham / Alex Copello / Birchwood, Max J., et al. (eds.)Substance Misuse in Psychosis97,99 €
- Bipolar Disorder298,99 €
- Frank W. Bond / Windy Dryden (Hgg.)Handbook of Brief Cognitive Behaviour Therapy369,99 €
- Cognitive Behavior Therapy107,99 €
- Robert Holman CoombsThe Addiction Counselor's Desk Reference88,99 €
-
-
-
There is constant pressure for clinicians to practise evidence-based medicine. Cochrane Reviews are an important source of the evidence which informs clinical decisions but can still require considerable time to read and digest. This Cochrane Handbook of Alcohol and Drug Misuse serves as a concise guide to the evidence base for relevant interventions, highlighting the key points of Cochrane reviews for the busy practitioner.
Each review is analysed in a structured format, starting with the question, a brief background and a summary answer, followed by the results presented in comprehensive and concise way. The authors then illustrate the value that the review adds to the current knowledge, the main methodological limitations of the included studies and finally the implications of the review's conclusions for future research.
Addiction to drugs and alcohol is an increasing problem that all clinicians have to deal with. This is especially true for medical and family specialists but more so for those dealing with psychiatric, psychological and social problems. The benefit of having the evidence underpinning the clinical approach to all aspects of this topic cannot be underestimated.
The book's comprehensive coverage of interventions provides an authoritative reference for all physicians working with these patients, from family practitioners to clinical specialists and psychiatric specialists. With addiction to drugs and alcohol an increasingly serious morbidity and public health issue, this book from the Cochrane Collaboration will find a wide audience.
Each review is analysed in a structured format, starting with the question, a brief background and a summary answer, followed by the results presented in comprehensive and concise way. The authors then illustrate the value that the review adds to the current knowledge, the main methodological limitations of the included studies and finally the implications of the review's conclusions for future research.
Addiction to drugs and alcohol is an increasing problem that all clinicians have to deal with. This is especially true for medical and family specialists but more so for those dealing with psychiatric, psychological and social problems. The benefit of having the evidence underpinning the clinical approach to all aspects of this topic cannot be underestimated.
The book's comprehensive coverage of interventions provides an authoritative reference for all physicians working with these patients, from family practitioners to clinical specialists and psychiatric specialists. With addiction to drugs and alcohol an increasingly serious morbidity and public health issue, this book from the Cochrane Collaboration will find a wide audience.
Produktdetails
- Produktdetails
- Cochrane Book Series (CBS) .
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 168
- Erscheinungstermin: 1. Oktober 2012
- Englisch
- Abmessung: 216mm x 136mm x 10mm
- Gewicht: 194g
- ISBN-13: 9780470659694
- ISBN-10: 0470659696
- Artikelnr.: 35941251
- Cochrane Book Series (CBS) .
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 168
- Erscheinungstermin: 1. Oktober 2012
- Englisch
- Abmessung: 216mm x 136mm x 10mm
- Gewicht: 194g
- ISBN-13: 9780470659694
- ISBN-10: 0470659696
- Artikelnr.: 35941251
Iosief Abraha MD and Cristina Cusi MD are reviewers in the Cochrane Neurological Network based in Italy. They have carried out Cochrane reviews in a wide range of areas within the Cochrane review groups and specialised in reviewing drug and alcohol withdrawal treatments
Foreword, ix Preface, xi Acknowledgements, xii Part 1: Alcohol Psychosocial
interventions Chapter 1: Effectiveness of brief alcohol interventions in
primary care populations, 1 Chapter 2: Brief interventions for heavy
alcohol users admitted to general hospital wards, 5 Chapter 3: Alcoholics
Anonymous and other 12-step programmes for alcohol dependence, 8 Chapter 4:
Mentoring adolescents to prevent substance use disorders, 10 Chapter 5:
Universal school-based prevention programmes for alcohol misuse in young
people, 12 Chapter 6: Universal multicomponent prevention programmes for
alcohol misuse in young people, 15 Chapter 7: Universal family-based
prevention programmes for alcohol misuse in young people, 17 Chapter 8:
Social norms interventions to reduce alcohol misuse in university or
college students, 19 Chapter 9: Psychosocial interventions for women
enrolled in alcohol treatment during pregnancy, 22 Pharmacological
interventions Chapter 10: Benzodiazepines for alcohol withdrawal, 24
Chapter 11: Anticonvulsants for alcohol withdrawal, 27 Chapter 12:
Acamprosate for alcohol dependence, 31 Chapter 13: Baclofen for alcohol
withdrawal, 34 Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol
withdrawal and prevention of relapse, 36 Chapter 15: Psychotropic analgesic
nitrous oxide for alcohol withdrawal, 40 Chapter 16: Efficacy and safety of
pharmacological interventions for the treatment of alcohol withdrawal, 43
Chapter 17: Opioid antagonists for alcohol dependence, 46 Chapter 18:
Pharmacologic interventions for pregnant women enrolled in alcohol
treatment, 49 Part 2: Drugs Psychosocial interventions Chapter 19:
School-based prevention for illicit substance use disorders, 51 Chapter 20:
Interventions for prevention of substance use disorders by young people
delivered in non-school settings, 54 Chapter 21: Case management for
persons with substance use disorders, 56 Chapter 22: Motivational
interviewing for substance use disorders, 59 Chapter 23: Therapeutic
communities for substance use disorders, 62 Chapter 24: Interventions for
drug-using offenders in the courts, secure establishments and the
community, 64 Chapter 25: Psychosocial interventions for pregnant women in
outpatient illicit drug treatment programmes compared to other
interventions, 67 Cocaine dependence Chapter 26 Psychosocial interventions
for cocaine and psychostimulant amphetamine related disorders, 69 Chapter
27: Antidepressants for cocaine dependence, 71 Chapter 28: Antipsychotic
medications for cocaine dependence, 74 Chapter 29: Anticonvulsants for
cocaine dependence, 76 Chapter 30: Dopamine agonists for cocaine
dependence, 78 Chapter 31: Disulfiram for the treatment of cocaine
dependence, 82 Chapter 32: Efficacy of psychostimulant drugs for cocaine
dependence, 84 Chapter 33: Auricular acupuncture for cocaine dependence, 87
Chapter 34: Psychosocial treatment for opiate dependence, 89 Chapter 35:
Psychosocial and pharmacological treatments versus pharmacological
treatments for opioid detoxification, 91 Chapter 36: Psychosocial combined
with agonist maintenance treatments versus agonist maintenance treatments
alone for treatment of opioid dependence, 94 Chapter 37: Alpha withdrawal,
96 Chapter 38: Buprenorphine for the management of opioid withdrawal, 99
Chapter 39: Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence, 102 Chapter 40: Methadone at tapered
doses for the management of opioid withdrawal, 105 Chapter 41: Methadone
maintenance at different dosages for opioid dependence, 108 Chapter 42:
Methadone maintenance therapy versus no opioid replacement therapy for
opioid dependence, 110 Chapter 43: Opioid antagonists under heavy sedation
or anaesthesia for opioid withdrawal, 113 Chapter 44: Opioid antagonists
with minimal sedation for opioid withdrawal, 115 Chapter 45: Oral
naltrexone maintenance treatment for opioid dependence, 118 Chapter 46:
Sustained-release naltrexone for opioid dependence, 121 Chapter 47: Heroin
maintenance for chronic heroin-dependent individuals, 123 Chapter 48: LAAM
maintenance versus methadone maintenance for heroin dependence, 126 Chapter
49: Detoxification treatments for opiate-dependent adolescents, 129 Chapter
50: Maintenance treatments for opiate-dependent adolescents, 131 Chapter
51: Maintenance agonist treatments for opiate-dependent pregnant women, 133
Chapter 52: Pharmacological treatment for depression during opioid agonist
treatment for opioid dependence, 135 Chapter 53: Inpatient versus other
settings for detoxification for opioid dependence, 138 Chapter 54:
Psychotherapeutic interventions for cannabis use or dependence in
outpatient settings, 140 Chapter 55: Pharmacological interventions for
benzodiazepine mono-dependence management in outpatient settings, 142
Chapter 56: Treatment for amphetamine dependence, 145 Chapter 57: Treatment
for amphetamine withdrawal, 147 Chapter 58: Treatment for amphetamine
psychosis, 149 Chapter 59: Treatment for methaqualone dependence in adults,
151 Index, 153
interventions Chapter 1: Effectiveness of brief alcohol interventions in
primary care populations, 1 Chapter 2: Brief interventions for heavy
alcohol users admitted to general hospital wards, 5 Chapter 3: Alcoholics
Anonymous and other 12-step programmes for alcohol dependence, 8 Chapter 4:
Mentoring adolescents to prevent substance use disorders, 10 Chapter 5:
Universal school-based prevention programmes for alcohol misuse in young
people, 12 Chapter 6: Universal multicomponent prevention programmes for
alcohol misuse in young people, 15 Chapter 7: Universal family-based
prevention programmes for alcohol misuse in young people, 17 Chapter 8:
Social norms interventions to reduce alcohol misuse in university or
college students, 19 Chapter 9: Psychosocial interventions for women
enrolled in alcohol treatment during pregnancy, 22 Pharmacological
interventions Chapter 10: Benzodiazepines for alcohol withdrawal, 24
Chapter 11: Anticonvulsants for alcohol withdrawal, 27 Chapter 12:
Acamprosate for alcohol dependence, 31 Chapter 13: Baclofen for alcohol
withdrawal, 34 Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol
withdrawal and prevention of relapse, 36 Chapter 15: Psychotropic analgesic
nitrous oxide for alcohol withdrawal, 40 Chapter 16: Efficacy and safety of
pharmacological interventions for the treatment of alcohol withdrawal, 43
Chapter 17: Opioid antagonists for alcohol dependence, 46 Chapter 18:
Pharmacologic interventions for pregnant women enrolled in alcohol
treatment, 49 Part 2: Drugs Psychosocial interventions Chapter 19:
School-based prevention for illicit substance use disorders, 51 Chapter 20:
Interventions for prevention of substance use disorders by young people
delivered in non-school settings, 54 Chapter 21: Case management for
persons with substance use disorders, 56 Chapter 22: Motivational
interviewing for substance use disorders, 59 Chapter 23: Therapeutic
communities for substance use disorders, 62 Chapter 24: Interventions for
drug-using offenders in the courts, secure establishments and the
community, 64 Chapter 25: Psychosocial interventions for pregnant women in
outpatient illicit drug treatment programmes compared to other
interventions, 67 Cocaine dependence Chapter 26 Psychosocial interventions
for cocaine and psychostimulant amphetamine related disorders, 69 Chapter
27: Antidepressants for cocaine dependence, 71 Chapter 28: Antipsychotic
medications for cocaine dependence, 74 Chapter 29: Anticonvulsants for
cocaine dependence, 76 Chapter 30: Dopamine agonists for cocaine
dependence, 78 Chapter 31: Disulfiram for the treatment of cocaine
dependence, 82 Chapter 32: Efficacy of psychostimulant drugs for cocaine
dependence, 84 Chapter 33: Auricular acupuncture for cocaine dependence, 87
Chapter 34: Psychosocial treatment for opiate dependence, 89 Chapter 35:
Psychosocial and pharmacological treatments versus pharmacological
treatments for opioid detoxification, 91 Chapter 36: Psychosocial combined
with agonist maintenance treatments versus agonist maintenance treatments
alone for treatment of opioid dependence, 94 Chapter 37: Alpha withdrawal,
96 Chapter 38: Buprenorphine for the management of opioid withdrawal, 99
Chapter 39: Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence, 102 Chapter 40: Methadone at tapered
doses for the management of opioid withdrawal, 105 Chapter 41: Methadone
maintenance at different dosages for opioid dependence, 108 Chapter 42:
Methadone maintenance therapy versus no opioid replacement therapy for
opioid dependence, 110 Chapter 43: Opioid antagonists under heavy sedation
or anaesthesia for opioid withdrawal, 113 Chapter 44: Opioid antagonists
with minimal sedation for opioid withdrawal, 115 Chapter 45: Oral
naltrexone maintenance treatment for opioid dependence, 118 Chapter 46:
Sustained-release naltrexone for opioid dependence, 121 Chapter 47: Heroin
maintenance for chronic heroin-dependent individuals, 123 Chapter 48: LAAM
maintenance versus methadone maintenance for heroin dependence, 126 Chapter
49: Detoxification treatments for opiate-dependent adolescents, 129 Chapter
50: Maintenance treatments for opiate-dependent adolescents, 131 Chapter
51: Maintenance agonist treatments for opiate-dependent pregnant women, 133
Chapter 52: Pharmacological treatment for depression during opioid agonist
treatment for opioid dependence, 135 Chapter 53: Inpatient versus other
settings for detoxification for opioid dependence, 138 Chapter 54:
Psychotherapeutic interventions for cannabis use or dependence in
outpatient settings, 140 Chapter 55: Pharmacological interventions for
benzodiazepine mono-dependence management in outpatient settings, 142
Chapter 56: Treatment for amphetamine dependence, 145 Chapter 57: Treatment
for amphetamine withdrawal, 147 Chapter 58: Treatment for amphetamine
psychosis, 149 Chapter 59: Treatment for methaqualone dependence in adults,
151 Index, 153
Foreword, ix Preface, xi Acknowledgements, xii Part 1: Alcohol Psychosocial
interventions Chapter 1: Effectiveness of brief alcohol interventions in
primary care populations, 1 Chapter 2: Brief interventions for heavy
alcohol users admitted to general hospital wards, 5 Chapter 3: Alcoholics
Anonymous and other 12-step programmes for alcohol dependence, 8 Chapter 4:
Mentoring adolescents to prevent substance use disorders, 10 Chapter 5:
Universal school-based prevention programmes for alcohol misuse in young
people, 12 Chapter 6: Universal multicomponent prevention programmes for
alcohol misuse in young people, 15 Chapter 7: Universal family-based
prevention programmes for alcohol misuse in young people, 17 Chapter 8:
Social norms interventions to reduce alcohol misuse in university or
college students, 19 Chapter 9: Psychosocial interventions for women
enrolled in alcohol treatment during pregnancy, 22 Pharmacological
interventions Chapter 10: Benzodiazepines for alcohol withdrawal, 24
Chapter 11: Anticonvulsants for alcohol withdrawal, 27 Chapter 12:
Acamprosate for alcohol dependence, 31 Chapter 13: Baclofen for alcohol
withdrawal, 34 Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol
withdrawal and prevention of relapse, 36 Chapter 15: Psychotropic analgesic
nitrous oxide for alcohol withdrawal, 40 Chapter 16: Efficacy and safety of
pharmacological interventions for the treatment of alcohol withdrawal, 43
Chapter 17: Opioid antagonists for alcohol dependence, 46 Chapter 18:
Pharmacologic interventions for pregnant women enrolled in alcohol
treatment, 49 Part 2: Drugs Psychosocial interventions Chapter 19:
School-based prevention for illicit substance use disorders, 51 Chapter 20:
Interventions for prevention of substance use disorders by young people
delivered in non-school settings, 54 Chapter 21: Case management for
persons with substance use disorders, 56 Chapter 22: Motivational
interviewing for substance use disorders, 59 Chapter 23: Therapeutic
communities for substance use disorders, 62 Chapter 24: Interventions for
drug-using offenders in the courts, secure establishments and the
community, 64 Chapter 25: Psychosocial interventions for pregnant women in
outpatient illicit drug treatment programmes compared to other
interventions, 67 Cocaine dependence Chapter 26 Psychosocial interventions
for cocaine and psychostimulant amphetamine related disorders, 69 Chapter
27: Antidepressants for cocaine dependence, 71 Chapter 28: Antipsychotic
medications for cocaine dependence, 74 Chapter 29: Anticonvulsants for
cocaine dependence, 76 Chapter 30: Dopamine agonists for cocaine
dependence, 78 Chapter 31: Disulfiram for the treatment of cocaine
dependence, 82 Chapter 32: Efficacy of psychostimulant drugs for cocaine
dependence, 84 Chapter 33: Auricular acupuncture for cocaine dependence, 87
Chapter 34: Psychosocial treatment for opiate dependence, 89 Chapter 35:
Psychosocial and pharmacological treatments versus pharmacological
treatments for opioid detoxification, 91 Chapter 36: Psychosocial combined
with agonist maintenance treatments versus agonist maintenance treatments
alone for treatment of opioid dependence, 94 Chapter 37: Alpha withdrawal,
96 Chapter 38: Buprenorphine for the management of opioid withdrawal, 99
Chapter 39: Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence, 102 Chapter 40: Methadone at tapered
doses for the management of opioid withdrawal, 105 Chapter 41: Methadone
maintenance at different dosages for opioid dependence, 108 Chapter 42:
Methadone maintenance therapy versus no opioid replacement therapy for
opioid dependence, 110 Chapter 43: Opioid antagonists under heavy sedation
or anaesthesia for opioid withdrawal, 113 Chapter 44: Opioid antagonists
with minimal sedation for opioid withdrawal, 115 Chapter 45: Oral
naltrexone maintenance treatment for opioid dependence, 118 Chapter 46:
Sustained-release naltrexone for opioid dependence, 121 Chapter 47: Heroin
maintenance for chronic heroin-dependent individuals, 123 Chapter 48: LAAM
maintenance versus methadone maintenance for heroin dependence, 126 Chapter
49: Detoxification treatments for opiate-dependent adolescents, 129 Chapter
50: Maintenance treatments for opiate-dependent adolescents, 131 Chapter
51: Maintenance agonist treatments for opiate-dependent pregnant women, 133
Chapter 52: Pharmacological treatment for depression during opioid agonist
treatment for opioid dependence, 135 Chapter 53: Inpatient versus other
settings for detoxification for opioid dependence, 138 Chapter 54:
Psychotherapeutic interventions for cannabis use or dependence in
outpatient settings, 140 Chapter 55: Pharmacological interventions for
benzodiazepine mono-dependence management in outpatient settings, 142
Chapter 56: Treatment for amphetamine dependence, 145 Chapter 57: Treatment
for amphetamine withdrawal, 147 Chapter 58: Treatment for amphetamine
psychosis, 149 Chapter 59: Treatment for methaqualone dependence in adults,
151 Index, 153
interventions Chapter 1: Effectiveness of brief alcohol interventions in
primary care populations, 1 Chapter 2: Brief interventions for heavy
alcohol users admitted to general hospital wards, 5 Chapter 3: Alcoholics
Anonymous and other 12-step programmes for alcohol dependence, 8 Chapter 4:
Mentoring adolescents to prevent substance use disorders, 10 Chapter 5:
Universal school-based prevention programmes for alcohol misuse in young
people, 12 Chapter 6: Universal multicomponent prevention programmes for
alcohol misuse in young people, 15 Chapter 7: Universal family-based
prevention programmes for alcohol misuse in young people, 17 Chapter 8:
Social norms interventions to reduce alcohol misuse in university or
college students, 19 Chapter 9: Psychosocial interventions for women
enrolled in alcohol treatment during pregnancy, 22 Pharmacological
interventions Chapter 10: Benzodiazepines for alcohol withdrawal, 24
Chapter 11: Anticonvulsants for alcohol withdrawal, 27 Chapter 12:
Acamprosate for alcohol dependence, 31 Chapter 13: Baclofen for alcohol
withdrawal, 34 Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol
withdrawal and prevention of relapse, 36 Chapter 15: Psychotropic analgesic
nitrous oxide for alcohol withdrawal, 40 Chapter 16: Efficacy and safety of
pharmacological interventions for the treatment of alcohol withdrawal, 43
Chapter 17: Opioid antagonists for alcohol dependence, 46 Chapter 18:
Pharmacologic interventions for pregnant women enrolled in alcohol
treatment, 49 Part 2: Drugs Psychosocial interventions Chapter 19:
School-based prevention for illicit substance use disorders, 51 Chapter 20:
Interventions for prevention of substance use disorders by young people
delivered in non-school settings, 54 Chapter 21: Case management for
persons with substance use disorders, 56 Chapter 22: Motivational
interviewing for substance use disorders, 59 Chapter 23: Therapeutic
communities for substance use disorders, 62 Chapter 24: Interventions for
drug-using offenders in the courts, secure establishments and the
community, 64 Chapter 25: Psychosocial interventions for pregnant women in
outpatient illicit drug treatment programmes compared to other
interventions, 67 Cocaine dependence Chapter 26 Psychosocial interventions
for cocaine and psychostimulant amphetamine related disorders, 69 Chapter
27: Antidepressants for cocaine dependence, 71 Chapter 28: Antipsychotic
medications for cocaine dependence, 74 Chapter 29: Anticonvulsants for
cocaine dependence, 76 Chapter 30: Dopamine agonists for cocaine
dependence, 78 Chapter 31: Disulfiram for the treatment of cocaine
dependence, 82 Chapter 32: Efficacy of psychostimulant drugs for cocaine
dependence, 84 Chapter 33: Auricular acupuncture for cocaine dependence, 87
Chapter 34: Psychosocial treatment for opiate dependence, 89 Chapter 35:
Psychosocial and pharmacological treatments versus pharmacological
treatments for opioid detoxification, 91 Chapter 36: Psychosocial combined
with agonist maintenance treatments versus agonist maintenance treatments
alone for treatment of opioid dependence, 94 Chapter 37: Alpha withdrawal,
96 Chapter 38: Buprenorphine for the management of opioid withdrawal, 99
Chapter 39: Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence, 102 Chapter 40: Methadone at tapered
doses for the management of opioid withdrawal, 105 Chapter 41: Methadone
maintenance at different dosages for opioid dependence, 108 Chapter 42:
Methadone maintenance therapy versus no opioid replacement therapy for
opioid dependence, 110 Chapter 43: Opioid antagonists under heavy sedation
or anaesthesia for opioid withdrawal, 113 Chapter 44: Opioid antagonists
with minimal sedation for opioid withdrawal, 115 Chapter 45: Oral
naltrexone maintenance treatment for opioid dependence, 118 Chapter 46:
Sustained-release naltrexone for opioid dependence, 121 Chapter 47: Heroin
maintenance for chronic heroin-dependent individuals, 123 Chapter 48: LAAM
maintenance versus methadone maintenance for heroin dependence, 126 Chapter
49: Detoxification treatments for opiate-dependent adolescents, 129 Chapter
50: Maintenance treatments for opiate-dependent adolescents, 131 Chapter
51: Maintenance agonist treatments for opiate-dependent pregnant women, 133
Chapter 52: Pharmacological treatment for depression during opioid agonist
treatment for opioid dependence, 135 Chapter 53: Inpatient versus other
settings for detoxification for opioid dependence, 138 Chapter 54:
Psychotherapeutic interventions for cannabis use or dependence in
outpatient settings, 140 Chapter 55: Pharmacological interventions for
benzodiazepine mono-dependence management in outpatient settings, 142
Chapter 56: Treatment for amphetamine dependence, 145 Chapter 57: Treatment
for amphetamine withdrawal, 147 Chapter 58: Treatment for amphetamine
psychosis, 149 Chapter 59: Treatment for methaqualone dependence in adults,
151 Index, 153